Results indicate substantial cross-ancestry sharing of breast cancer polygenic architecture, highlight a consistent contribution of regulatory variation, and identify convergent cellular contexts that motivate functional follow-up and inform expectations for the transferability and attainable performance of common-variant risk prediction across populations.
Abstract
Background
Breast cancer genome-wide association studies (GWAS) have identified more than 200 susceptibility loci, but most studies are dominated by European and East Asian populations.
Methods
We analyzed breast cancer GWAS summary statistics from African (AFR), East Asian (EAS), European (EUR), and Hispanic/Latina (H/L) samples (159,297 cases and 212,102 controls). We estimated logit-scale SNP-based heritability, polygenicity, and cross-ancestry genetic correlation, partitioned heritability across functional annotations, and integrated GWAS results with the Tabula Sapiens single-cell atlas using scDRS+.
Results
The logit-scale heritability of breast cancer ranged from h2=0.47 (SE = 0.07) in EAS to AFR h2=0.61 (SE = 0.10), with no significant differences across ancestries (p = 0.63). The model-implied number of non-null susceptibility SNPs in the sparse normal-mixture effect-size model also varied from 4,446 (SE = 3,100) in EAS to 8,308 (SE = 2,751) in AFR, but differences were not significant across ancestries (p = 0.55). Cross-sample genetic correlations varied, with the strongest correlation between EUR and EAS (ρ=0.79, SE = 0.08) and weakest between AFR and H/L (ρ=0.26, SE = 0.24). Regulatory annotations were enriched for breast cancer heritability across samples. Integration with single-cell expression profiles implicated ancestry-shared associations with innate immune, secretory epithelial, and stromal cell types.
Conclusion
These results indicate substantial cross-ancestry sharing of breast cancer polygenic architecture, highlight a consistent contribution of regulatory variation, and identify convergent cellular contexts that motivate functional follow-up and inform expectations for the transferability and attainable performance of common-variant risk prediction across populations.
The 8q24 region is a major prostate cancer susceptibility locus, but variant effects may differ across ancestry-associated haplotype contexts. We analyzed whole genome sequencing and electronic health record data from 166,155 male participants in the NIH All of Us Research Program (10,166 cases and 155,989 controls). A...
A cross-population genome-wide association meta-analysis of 11 GWAS summary-statistic datasets comprises 20,120 pancreatic cancer cases and 1,446,192 controls genetically similar to European or East Asian reference populations refine the genetic architecture of pancreatic cancer and provide insights into candidate gene...
The observed genetic correlations are consistent with shared genetic liability between DED and chronic pain, autoimmune, and psychiatric traits, but do not establish causal direction.
Bryan R. Gorman, Jaxon J. Huang, Peter B. Barr et al.· EBioMedicine· 0 citations
Breast cancer susceptibility loci identified by genome-wide association studies (GWAS) have revealed extensive genetic contribution to disease risk, yet the genes and immune regulatory mechanisms underlying these associations remain largely unresolved. Here, we integrated immune-cell-specific cis-eQTL data with breast...
Fu-Lei Han, Rong-Rong Zhao, Hai-Ning Yu et al.· Cancer Genetics· 0 citations
Polygenic risk scores (PGS) for four most common cancers showed predictive performance broadly consistent with previous studies, including association between PGS and earlier age at prostate cancer diagnosis, and no meaningful differences in cancer stage at diagnosis by PGS.
H. M. Tanha, D. Goldsbury, R. Parker et al.· medRxiv· 0 citations
Integrating statistical genetics, regulatory prediction, and locus‐directed experiments prioritized SMAD9, MAP3K2, FADS1, and ACTR1B as CRC susceptibility genes, and placed experimental bounds on the proposed MAP3K2 and ACTR1B mechanisms.
Chengguang Hu, Guang Yang, Han Xiong et al.· Human Mutation· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.